Unknown

Dataset Information

0

Estimation of SARS-CoV-2 Infection Fatality Rate by Age and Comorbidity Status Using Antibody Screening of Blood Donors During the COVID-19 Epidemic in Denmark.


ABSTRACT:

Background

Studies presenting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection fatality rate (IFR) for healthy individuals are warranted. We estimate IFR by age and comorbidity status using data from a large serosurvey among Danish blood donors and nationwide data on coronavirus disease 2019 (COVID-19) mortality.

Methods

Danish blood donors aged 17-69 years donating blood October 2020-February 2021 were tested with a commercial SARS-CoV-2 total antibody assay. IFR was estimated for weeks 11 to 42, 2020 and week 43, 2020 to week 6, 2021, representing the first 2 waves of COVID-19 epidemic in Denmark.

Results

In total, 84944 blood donors were tested for antibodies. The seroprevalence was 2% in October 2020 and 7% in February 2021. Among 3898039 Danish residents aged 17-69 years, 249 deaths were recorded. The IFR was low for people <51 years without comorbidity during the 2 waves (combined IFR=3.36 per 100000 infections). The IFR was below 3‰ for people aged 61-69 years without comorbidity. IFR increased with age and comorbidity but declined from the first to second wave.

Conclusions

In this nationwide study, the IFR was very low among people <51 years without comorbidity.

SUBMITTER: Kaspersen KA 

PROVIDER: S-EPMC8689980 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>Studies presenting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection fatality rate (IFR) for healthy individuals are warranted. We estimate IFR by age and comorbidity status using data from a large serosurvey among Danish blood donors and nationwide data on coronavirus disease 2019 (COVID-19) mortality.<h4>Methods</h4>Danish blood donors aged 17-69 years donating blood October 2020-February 2021 were tested with a commercial SARS-CoV-2 total antibody assay  ...[more]

Similar Datasets

| S-EPMC7486824 | biostudies-literature
| S-EPMC5596001 | biostudies-literature
| S-EPMC8903396 | biostudies-literature
| S-EPMC8704731 | biostudies-literature
| S-EPMC7899354 | biostudies-literature
| S-EPMC9355516 | biostudies-literature
| S-EPMC5553941 | biostudies-other
| S-EPMC8785264 | biostudies-literature
| S-EPMC7482605 | biostudies-literature
| S-EPMC8093857 | biostudies-literature